These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3821042)

  • 1. [Condition of hemostasis in the hemorrhagic syndrome of erysipelas patients].
    Bokarev IN; Cherkasov VL; Babakulieva TKh; Nesterova SG; Kabaeva EV
    Klin Med (Mosk); 1986 Nov; 64(11):88-91. PubMed ID: 3821042
    [No Abstract]   [Full Text] [Related]  

  • 2. [The heparin and trental treatment of patients with the hemorrhagic form of erysipelas].
    Cherkasov VL; Nakisbekova GO; Smolianitskiĭ AIa; Samotolkin KN
    Vrach Delo; 1991 Oct; (10):105-8. PubMed ID: 1803730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of hemostasis and fibrinolysis in hemorrhagic erysipelas].
    Cherkasov VIa; Bokarev IN; Babakulieva TKh; Dynkina IM; Detinkina GN; Nesterova SG; Smolianitskiĭ AIa; Nakisbekova GO
    Sov Med; 1989; (10):105-8. PubMed ID: 2617332
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the kallikrein-kinin system of patients with erythematous and hemorrhagic forms of erysipelas].
    Ambalov IuM; Levina LD; Aĭtkuluev NS; Kovalenko AP; Usatkin AV
    Vrach Delo; 1991 Nov; (11):92-5. PubMed ID: 1801446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of erythrocyte electrophoretic mobility in patients with various forms of erysipelas].
    Erovichenkov AA; Sadovskaia GV; Pak SG; Kozinets GI; Popova OV
    Ter Arkh; 2001; 73(11):73-5. PubMed ID: 11806213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Several indices of the coagulation and fibrinolytic activity of blood in patients with erysipelas].
    Kireeva RIa
    Klin Med (Mosk); 1970 Mar; 48(3):107-11. PubMed ID: 5452153
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hemostatic system of patients with a severe course of viral hepatitis E].
    Poliakova AM; Novozhenina EB; Danil'iants IL
    Ter Arkh; 1994; 66(11):19-21. PubMed ID: 7900005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parameters of the procoagulant component of the hemostasis and fibrinolysis system in patients with steroid-dependent bronchial asthma complicated by the cutaneous hemorrhagic syndrome].
    Daniliak IG; Tursunov KhKh; Smolianitskiĭ AIa; Torik ZhN; Dynkina IM; Detinkina GN; Nesterova SG
    Ter Arkh; 1991; 63(3):78-81. PubMed ID: 2063342
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of patients with the hemorrhagic form of erysipelas by using amben and parmidine].
    Cherkasov VL; Bol'shakova TD; Kuznetsov VA; Obrazberdyev S; Mikerin SM
    Vrach Delo; 1990 Apr; (4):113-5. PubMed ID: 2275146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoglobulin content and immunoelectrophoretic assay of blood serum in patients with various forms of erysipelas].
    Gordinskaia NM; Starostina IS
    Ter Arkh; 1976; 48(12):57-61. PubMed ID: 65018
    [No Abstract]   [Full Text] [Related]  

  • 11. [The hemostatic system in patients with viral hepatitis C].
    Novozhenina EV; Kuznetsova EN; Poliakova AM; Danil'iants IL
    Klin Med (Mosk); 1996; 74(1):38-40. PubMed ID: 8649006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinic-laboratory characteristics of recurrence erysipelas].
    Rychnev VE; Frolov VM; Shlykova SI; Peresadin NA; Zeĭtlenok DIu
    Sov Med; 1982; (3):102-4. PubMed ID: 6179165
    [No Abstract]   [Full Text] [Related]  

  • 13. [The application wound sorption in complex treatment of destructive forms of erysipelas inflammation].
    Rybachkov VV; Potapov PP; Sal'nikov EV; Kabanov EN
    Vestn Khir Im I I Grek; 2003; 162(5):82-4. PubMed ID: 14768113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and anticoagulation systems in erysipelas].
    Radkevich RA; Ryskind RR; Guseva TM
    Sov Med; 1973 May; 36(5):147. PubMed ID: 4768334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostaglandins in erysipelas].
    Cherkasov VL; Bol'shakova TD; Meshcheriakova SV; Mikerin SM
    Sov Med; 1986; (8):26-8. PubMed ID: 3465043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic corticosteroids and their place in the management of hemorrhagic erysipelas].
    Ezzine Sebai N; Hicheri J; Trojjet S; Khaled A; Badri T; Zeglaoui F; Fezaa B; Ridha Kamoun M
    Tunis Med; 2008 Jan; 86(1):49-52. PubMed ID: 19472700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between erysipelas of the lower extremities and mycoses of the foot].
    Svirid SG; Dubrovskiĭ NI; Svirid GM
    Vrach Delo; 1987 Jun; (6):115. PubMed ID: 2820154
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the hemostatic status during operations on cancer patients depending on the volume of blood loss].
    Madzhuga AV; Somonova OV; Solov'eva EA; Kononenko LP; Komarova IN
    Anesteziol Reanimatol; 1985; (3):38-40. PubMed ID: 4051237
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation state in pulmonary tuberculosis complicated by the hemorrhagic syndrome].
    Grigor'ev IuG; Guseva TM
    Probl Tuberk; 1980 May; (5):43-6. PubMed ID: 7384047
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemorrhagic syndrome due to hemostasis disorders. Diagnostic orientation].
    Brière J
    Rev Prat; 1991 Dec; 41(25):2617-22. PubMed ID: 1803477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.